Artificial Intelligence in Clinical Diagnosis

Main Article Content

Dr. Alexander James Moore

Abstract


Artificial intelligence (AI) can identify patterns in medical images, physiological signals and clinical records, offering support for screening, triage and selected diagnostic decisions. Its usefulness depends on the clinical question, patient population, reference standard, workflow and consequences of false results. This narrative review discusses diagnostic applications, study design, performance measures, external validation and ethical oversight. Published results from a prospective trial of an autonomous diabetic retinopathy system illustrate sensitivity, specificity and imageability in a defined primary-care setting. Those metrics cannot be generalized to other diseases or devices. Evidence from AI-assisted mammography shows how a system can be studied in a randomized screening workflow, while regulatory authorization remains tied to a specific intended use. Safe deployment requires data-quality checks, clear clinician and patient communication, referral pathways, monitoring for drift and evaluation of outcomes across patient groups.


Article Details

Section

Articles

References

[1] World Health Organization. (2021). Ethics and governance of artificial intelligence for health. https://www.who.int/publications/i/item/9789240029200

[2] US Food and Drug Administration. List of Artificial Intelligence-Enabled Medical Devices. https://www.fda.gov/medical-devices/artificial-intelligence-enabled-medical-devices/list-artificial-intelligence-enabled-medical-devices

[3] Abràmoff, M. D., Lavin, P. T., Birch, M., Shah, N., & Folk, J. C. (2018). Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. npj Digital Medicine, 1, 39. https://doi.org/10.1038/s41746-018-0040-6

[4] Lång, K., et al. (2023). Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): A clinical safety analysis. The Lancet Oncology. https://doi.org/10.1016/S1470-2045(23)00298-X